RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/18414472http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/18414472http://www.w3.org/2000/01/rdf-schema#comment"The Fanconi gene family has a role in DNA repair and inactivation of FANCF has been proposed as a mechanism of sensitisation to platinum chemotherapy. This study sought to confirm this hypothesis in cell lines and a large series of ovarian cancer samples. Promoter methylation was assessed by methylation-sensitive polymerase chain reaction of FANCF in nine ovarian cancer cell lines and 74 ovarian cancer samples taken from patients entered on a trial of cisplatin-based chemotherapy. This study confirmed methylation-dependent silencing of FANCF in one out of nine ovarian cancer cell lines. Methylation of FANCF was demonstrated in 13.2% of 53 evaluable ovarian tumour samples. Progression-free survival gave an HR of 3.63 (95% CI: 1.54-8.54, P=0.0016) in favour of the unmethylated cases. There was no association with overall survival. This study does not support methylation-dependent silencing of FANCF as a mechanism of sensitisation to platinum-based chemotherapy in ovarian cancer."xsd:string
http://purl.uniprot.org/citations/18414472http://purl.org/dc/terms/identifier"doi:10.1038/sj.bjc.6604325"xsd:string
http://purl.uniprot.org/citations/18414472http://purl.uniprot.org/core/author"Smith P."xsd:string
http://purl.uniprot.org/citations/18414472http://purl.uniprot.org/core/author"Crook T."xsd:string
http://purl.uniprot.org/citations/18414472http://purl.uniprot.org/core/author"van der Burg M."xsd:string
http://purl.uniprot.org/citations/18414472http://purl.uniprot.org/core/author"Wong H."xsd:string
http://purl.uniprot.org/citations/18414472http://purl.uniprot.org/core/author"Syed N."xsd:string
http://purl.uniprot.org/citations/18414472http://purl.uniprot.org/core/author"Lim S.L."xsd:string
http://purl.uniprot.org/citations/18414472http://purl.uniprot.org/core/author"Green J.A."xsd:string
http://purl.uniprot.org/citations/18414472http://purl.uniprot.org/core/author"Coens C."xsd:string
http://purl.uniprot.org/citations/18414472http://purl.uniprot.org/core/author"Szlosarek P."xsd:string
http://purl.uniprot.org/citations/18414472http://purl.uniprot.org/core/date"2008"xsd:gYear
http://purl.uniprot.org/citations/18414472http://purl.uniprot.org/core/name"Br J Cancer"xsd:string
http://purl.uniprot.org/citations/18414472http://purl.uniprot.org/core/pages"1452-1456"xsd:string
http://purl.uniprot.org/citations/18414472http://purl.uniprot.org/core/title"Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer."xsd:string
http://purl.uniprot.org/citations/18414472http://purl.uniprot.org/core/volume"98"xsd:string
http://purl.uniprot.org/citations/18414472http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/18414472
http://purl.uniprot.org/citations/18414472http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/18414472
http://purl.uniprot.org/uniprot/#_A3KME0-mappedCitation-18414472http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18414472
http://purl.uniprot.org/uniprot/#_Q9NPI8-mappedCitation-18414472http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18414472
http://purl.uniprot.org/uniprot/#_Q53FK7-mappedCitation-18414472http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18414472
http://purl.uniprot.org/uniprot/#_Q6MZN0-mappedCitation-18414472http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18414472
http://purl.uniprot.org/uniprot/Q6MZN0http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/18414472
http://purl.uniprot.org/uniprot/Q53FK7http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/18414472